semaglutide and heart attack reduces cardiovascular risk by 20 percent Why cardiologists may prescribe semaglutide

Although GLP-1 medications are not a direct hormonal therapy, they can indirectly support hormonal balance by improving insulin regulation and reducing inflammationboth of which can impact overall hormone health

Take both for maximum effect.

Preclinical studies demonstrated its ability to delay gastric emptying, reduce food intake, and promote weight loss, setting the stage for human trials

Your provider remains available for check-ins at four weeks, eight weeks, and twelve weeks to monitor your progress, adjust your dose as needed, and confirm that tirzepatide is delivering the results you expect

The FREEDOM trial, with a median follow-up of 1.33 years, did not demonstrate a statistically significant difference in four-point MACE (RR 1.21

Your neurologist should evaluate your specific MS status, current medications, and disease activity before approving semaglutide or other GLP-1 treatments